Portfolio Lab

Crocs, Inc.

  • Stock
  • Ticker CROX
  • ISIN US2270461096
  • Nasdaq

Materials · Chemicals · USA

$154.67 −1.68%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of Crocs, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

CROXGlobal equities (VT)

$10,000 grew to $188,622. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −75.2% in 03/2020, measured from the peak in 01/2020. It took 8 months to get back to the old peak.

1-year return
+97.0%
5-year return p.a.
−2.5%
10-year return p.a.
+34.1%
Volatility p.a.
50.2%
Largest decline
−75.2%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue9909371,1499969589211,1791,043
Gross profit573542709583524523701690
Operating income200223-428208146201286292
EBITDA218242-408228167221306313
Net income369160-492146105138205217
Earnings per share6.262.83-8.822.701.882.714.134.52
Balance sheet
Total assets4,8125,0664,4514,3004,1754,3434,3564,281
Liabilities2,9763,0973,0292,9372,8812,9162,9722,936
Equity1,8361,9701,4211,3631,2931,4271,3851,345
Cash180166201154130131170163
Long-term debt1,3491,4821,3791,3181,2311,3301,3081,289
Cash flow
Operating cash flow322-67286239253-81352290
Capital expenditure-18-15-17-13-6.1-18-21-15
Free cash flow303-83269226246-99331276

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2018 at +105.5%, weakest 2025 at −21.9%. 6 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
29 Oct 2026$4.52
30 Jul 2026$4.13
30 Apr 2026$2.71
12 Feb 2026$1.88
30 Oct 2025$2.70
7 Aug 2025−$8.82
8 May 2025$2.83
13 Feb 2025$6.26
29 Oct 2024$3.36
1 Aug 2024$3.77
7 May 2024$2.50
15 Feb 2024$4.14

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€6.4bn
Market cap in trading currency
$7.07bn
Enterprise value
$8.20bn
P/E
11.7
P/S
1.72
P/B
5.26
EV/Sales
2.00
EV/EBITDA
8.1
Earnings yield
8.6%
FCF yield
10.7%

Results (last four quarters)

Revenue
$4.10bn
Gross profit
$2.44bn
EBITDA
$1.01bn
Net income
$664m
Earnings per share
$13.24
Revenue per share
$89.69
Revenue growth
+4.6%
Earnings growth
+48.6%

Profitability

Gross margin
59.4%
Operating margin
22.6%
Net margin
16.2%
Return on equity
49.1%
Return on assets
15.5%

Balance sheet and cash flow

Cash
$163m
Cash per share
$3.57
Financial debt
$1.29bn
Debt/equity %
96
Current ratio
1.44
Book value per share
$29.42
Operating cash flow
$814m
Free cash flow
$754m

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
45.7m
Volume
1.06m
Avg. volume 3 months
1.17m
Relative volume
0.9

Price and technicals

Price
$154.67
1 day
−1.7%
52-week high
$163.72
52-week low
$75.78
Distance to 52-week high
−5.5%
Distance to 52-week low
+104.1%
Distance to 50-day line
+16.9%
Distance to 200-day line
+34.0%
RSI (14)
58
Volatility 1M
87.5%

Performance

1 week
−5.5%
1 month
+27.8%
3 months
+22.9%
6 months
+40.0%
YTD
+80.9%
1 year
+95.4%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has CROX performed since 11/2016?

$10,000 grew to $188,622 by 20 Nov 2026, which is +34.2% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is CROX?

Volatility was 50.2% per year, measured on monthly returns. The largest decline from a peak was −75.2%, with the low in 03/2020.

How does CROX compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, CROX returned +34.2% at 50.2%. The correlation of monthly returns was 0.52; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

Crocs, Inc. (CROX): Return and risk | Portfolio Lab